Drug Shortage Report for PREGABALIN
| Report ID | 143950 |
| Drug Identification Number | 02403730 |
| Brand name | PREGABALIN |
| Common or Proper name | PREGABALIN |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | PREGABALIN |
| Strength(s) | 300MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2021-08-30 |
| Actual start date | |
| Estimated end date | 2021-09-20 |
| Actual end date | 2021-10-01 |
| Shortage status | Resolved |
| Updated date | 2021-10-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2021-10-19 | French | Compare |
| v6 | 2021-10-19 | English | Compare |
| v5 | 2021-08-31 | English | Compare |
| v4 | 2021-08-17 | French | Compare |
| v3 | 2021-08-17 | English | Compare |
| v2 | 2021-08-11 | French | Compare |
| v1 | 2021-08-11 | English | Compare |
Showing 1 to 7 of 7